Prof Krish Ragunath MD DNB MPhil FRCP FRACP FASGE FJGES
Interventional Gastroenterologist, Royal Perth Hospital, Clinical Adjunct Professor, Curtin Medical
Prof Krish Ragunath is a UK trained Gastroenterologist and has a wealth of experience over two decades treating all gastroenterological disorders. Krish started his clinical academic career in 2003 at Nottingham University Hospital, UK. After having established a centre of excellence in Endoscopy at Nottingham he moved to Australia in 2019 under the Global Talent initiative.
He is currently Professor of Medicine at Curtin University Medical School, and Consultant Gastroenterologist at Royal Perth Hospital, Western Australia. His clinical and research interests include advanced endoscopic imaging of the GI Tract, Endoscopic Ultrasound, Barrett’s oesophagus and minimally invasive endoscopic therapy of early GI neoplasia.
He has co-edited the BSG Barrett's oesophagus guidelines, Quality standards in upper GI endoscopy, Guidelines for the management of gastric premalignant conditions and UK oesophageal dilatation guidelines. Has authored/co-authored 150 peer reviewed publications and text book chapters.
He is Endoscopy Faculty member of the Gastroenterological Society of Australia, Associate Editor for ‘Digestive Endoscopy’ journal, International member of the Editorial Board for 'Endoscopy', 'Gastrointestinal Endoscopy', and Translational Gastroenterology & Hepatology journals. He was the recipient of the British Society of Gastroenterology, Hopkins Endoscopy Prize 2010.
Publications
Fitzgerald RC, Di Pietro M, Ragunath K, Ang Y, Kang JY, Watson P, Trudgill N, Patel P, Kaye PV, Sanders S, O'Donovan M. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut. 2014 Jan 1;63(1):7-42.
Phoa KN, Van Vilsteren FG, Weusten BL, Bisschops R, Schoon EJ, Ragunath K, Fullarton G, Di Pietro M, Ravi N, Visser M, Offerhaus GJ. Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial. Jama. 2014 Mar 26;311(12):1209-17.
van der Post RS, Vogelaar IP, Carneiro F, Guilford P, Huntsman D, Hoogerbrugge N, Caldas C, Schreiber KE, Hardwick RH, Ausems MG, Bardram L. Ragunath K. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. Journal of medical genetics. 2015 Jun 1;52(6):361-74.
Banks M, Graham D, Jansen M, Gotoda T, Coda S, Di Pietro M, Uedo N, Bhandari P, Pritchard DM, Kuipers EJ, Rodriguez-Justo M. Ragunath K. British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut. 2019 Sep 1;68(9):1545-75.
Yao K, Anagnostopoulos GK, Ragunath K. Magnifying endoscopy for diagnosing and delineating early gastric cancer. Endoscopy. 2009 May;41(05):462-7.
Bennett C, Vakil N, Bergman J, Harrison R, Odze R, Vieth M, Sanders S, Gay L, Pech O, Longcroft–Wheaton G, Romero Y. Ragunath K. Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology. 2012 Aug 1;143(2):336-46.
Beg S, Ragunath K, Wyman A, Banks M, Trudgill N, Pritchard MD, Riley S, Anderson J, Griffiths H, Bhandari P, Kaye P. Quality standards in upper gastrointestinal endoscopy: a position statement of the British Society of Gastroenterology (BSG) and Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland (AUGIS). Gut. 2017 Nov 1;66(11):1886-99.
Yang LS, Halder A, Holt BA, Devereaux B, Remedios M, Merrett N, Lill M, Raos Z, Arnold M, Burgess NG, John S, Ragunath K. Quality Upper Gastrointestinal Endoscopy in Australia and Aotearoa New Zealand: A Joint Position Statement. J Gastroenterol Hepatol. 2025 Aug;40(8):1876-1889. doi: 10.1111/jgh.17013. Epub 2025 May 23. PMID: 40406805; PMCID: PMC12315793.